21 CFR 211.192 / 211.160 OOS Investigation · Pre-Inspection Review ComplianceWorxs · 2026
OOS investigation authorization gaps are among the most scrutinized findings in pharmaceutical inspections. The FDA's OOS guidance explicitly requires that investigation records support the conclusions reached — but most sites document the investigation thoroughly and leave the authorization decisions implicit. This checklist identifies each authorization decision point in the OOS process before the investigator does.
01 Phase I — Laboratory investigation authorization
Investigator's question

"Who determined the OOS result was attributable to laboratory error — and what is the record of that authorization?"

  • If assignable cause was identified in Phase I, a document exists identifying who authorized the invalidity conclusion — not just who investigated it
  • The specific evidence supporting the assignable cause conclusion is documented — not summarized as "analyst error confirmed"
  • The evidentiary standard applied to conclude assignable cause was established — what threshold of evidence was required before Phase I could support invalidity
  • If Phase I did not establish assignable cause, the decision to proceed to Phase II is documented as a formal authorization — not an implicit next step
02 Invalidity and retesting authorization
Investigator's question

"Who authorized the decision to invalidate this result or to retest — and what evidentiary standard supported that decision?"

  • Invalidity decisions are authorized by a qualified individual independent of the analyst — with the authorization documented separately from the investigation record
  • If retesting was authorized, the record documents who made the retesting decision — what basis supported retesting rather than rejection, and what protocol governed the number of retests
  • The pre-specified acceptance criteria for retest results are documented in the authorization record — not determined after the retest results are known
  • The authorization record for invalidity can be distinguished from the investigation record — it is clear which document captures the decision versus the investigation findings
03 Final disposition authorization
Investigator's question

"Who made the final product disposition decision — release, reject, or retest — and where is the authorization for that decision?"

  • The disposition decision has its own authorization record — separate from the investigation conclusion and the invalidity determination
  • The authorizing individual for the disposition decision is identified with their name, title, date, and the specific basis for the disposition conclusion
  • If the product was released following an OOS result, the authorization record demonstrates that all investigation activities were complete prior to the release authorization
  • The regulatory standard governing the disposition decision is cited — not just the specification, but the decision standard under 21 CFR 211.192
04 Investigation closure without identified root cause
Investigator's question

"If root cause was not identified, who authorized the conclusion that the investigation was complete — and what supported that determination?"

  • Inconclusive closures have a more complete authorization record, not a less complete one — documenting all investigation activities performed, why root cause was not identifiable, and who authorized the inconclusive determination
  • The specific investigation activities performed are documented — not summarized as "investigation conducted" — with results that support the inconclusive conclusion
  • The authorization record documents why additional investigation activities were not warranted — what alternatives were considered and why they were not pursued
The highest-scrutiny OOS gap

The investigation was complete. The invalidity authorization was not documented.

FDA investigators understand that OOS results require investigation. The gap that generates 483 observations is not an incomplete investigation — it is an investigation conclusion that was reached without a formal authorization record for the most consequential decision: who concluded the result was invalid, and on what evidentiary basis. The investigation tells the story. The authorization record names the decision-maker and the standard they applied.

The OOS Investigation Authorization case file produces a structured authorization record for every OOS decision point — Phase I conclusion, invalidity determination, and final disposition.

Get the Case File — $149 →